Alireza Ghajar

35 papers receiving 1.0k citations

Peers

Alireza Ghajar
Comparison fields: 5 of 96
  • Endocrinology, Diabetes and Metabolism 296
  • Pharmacology 198
  • Epidemiology 197
  • Biological Psychiatry 153
  • Cardiology and Cardiovascular Medicine 127
Replace Mohsen Afarideh with:
Mohsen Afarideh Iran
Ang Zhou Australia
Rebecca D. Jackson United States
Min Guo China
Samantha Kimball Canada
Aimilia Mantzou Greece
Maurı́cio Wajngarten Brazil
Markus Laimer Switzerland
Bom Taeck Kim South Korea
Maya Soni United Kingdom
Alireza Ghajar relative to Mohsen Afarideh Iran Mohsen Afarideh's profile →
Citations per field
00.5×1.5×
Mohsen Afarideh · 1×
Citations per year

Countries citing papers authored by Alireza Ghajar

Since Specialization
Citations

This map shows the geographic impact of Alireza Ghajar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alireza Ghajar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alireza Ghajar more than expected).

Fields of papers citing papers by Alireza Ghajar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alireza Ghajar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alireza Ghajar. The network helps show where Alireza Ghajar may publish in the future.

Co-authorship network of co-authors of Alireza Ghajar

This figure shows the co-authorship network connecting the top 25 collaborators of Alireza Ghajar. A scholar is included among the top collaborators of Alireza Ghajar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alireza Ghajar. Alireza Ghajar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 22
4 6
5 17
6 4
7 26
8 58
9 19
10 22
11 17
12 38
13 26
14 12
15 208
16 25
17 78
18 32
19 21
20 8

About Alireza Ghajar

Alireza Ghajar is a scholar working on Biological Psychiatry, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, having authored 38 papers that have together received 1.0k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Tryptophan and brain disorders (4 papers) and Blood Pressure and Hypertension Studies (3 papers). The work is most often cited by research in Biological Psychiatry (153 citations), Endocrinology, Diabetes and Metabolism (296 citations) and Behavioral Neuroscience (59 citations). Alireza Ghajar has collaborated with scholars based in Iran, United States and United Kingdom. Frequent co-authors include Mohsen Afarideh, Alireza Esteghamati, Shahin Akhondzadeh, Sina Noshad, Manouchehr Nakhjavani, Morsaleh Ganji, Morteza Jafarinia, Mohammad Saadat, Elias Khajeh and Jeffrey I. Mechanick. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and The American Journal of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026